Psychiatric co-morbidity and substance use disorders: Treatment in parallel systems or in one integrated system

Marta Torrens, Paola C. Rossi, Roser Martinez-Riera, Diana Martinez-Sanvisens, Antoni Bulbena

Producció científica: Contribució a una revistaArticleRecercaAvaluat per experts

81 Cites (Scopus)

Resum

Psychiatric co-morbidity among substance users refers to the simultaneous presence of at least another psychiatric disorder in a person diagnosed with a substance use disorder. Co-morbid patients represent a substantial number of people in treatment and present greater disorder severity from both the clinical and social perspectives than those people diagnosed with only one type of disorder. We present an overview of the current state of the art concerning the choice of site of treatment, the kind of intervention, the length of such treatment, and future goals, aiming to establish a more effective intervention, and finally so as to further improve clinical outcomes. © 2012 Informa Healthcare USA, Inc.
Idioma originalEnglish
Pàgines (de-a)1005-1014
RevistaSubstance Use and Misuse
Volum47
Número8-9
DOIs
Estat de la publicacióPublicada - 1 de juny 2012

Fingerprint

Navegar pels temes de recerca de 'Psychiatric co-morbidity and substance use disorders: Treatment in parallel systems or in one integrated system'. Junts formen un fingerprint únic.

Com citar-ho